Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation

医学 银屑病 临床试验 重症监护医学 皮肤病科 泛发性脓疱性银屑病 安全概况 不利影响 药品 药理学 内科学
作者
Luca Potestio,Elisa Camela,Sara Cacciapuoti,Fabrizio Martora,Luigi Guerriero,Luigi Fornaro,Angelo Ruggiero,Matteo Megna
出处
期刊:Expert Opinion on Drug Safety [Taylor & Francis]
卷期号:22 (11): 1003-1010 被引量:4
标识
DOI:10.1080/14740338.2023.2265295
摘要

Generalized pustular psoriasis (GPP) is a rare form of psoriasis (less of 1% of cases). Currently, GPP is recognized as a clinical entity, distinguished from plaque psoriasis. However, there are not guidelines for GPP management and treatments are often derived from plaque psoriasis. Therefore, conventional systemic drugs are usually used as first-line treatment options, and biologics are still used off label. Recently, spesolimab, an anti-IL36 receptor humanized IgG1 monoclonal antibody, has been specifically approved for GPP disease, revolutionizing treatment scenario.The aim of this review is to investigate current literature on the use of spesolimab for GPP management to underline its potential role in GPP and offer a current clinical perspective. Literature research using the Google Scholar, Pubmed, Embase, Cochrane Skin, and clinicaltrials.gov databases was performed, selecting the most relevant manuscripts.Spesolimab is efficacious and has a consistent and favorable safety profile in patients presenting with a GPP flare. However, despite excellent results in terms of safety and efficacy have been reported by both clinical trials and very limited real-life experiences, long-term data, especially in flare-up prevention, are scant. Thus, while the available data are encouraging, further research is warranted to understand the efficacy, safety, and long-term outcomes associated with spesolimab treatment in GPP.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
哇咔咔发布了新的文献求助10
刚刚
梨花诗关注了科研通微信公众号
1秒前
bkagyin的应助被江sir采纳,获得10
1秒前
藤原拓海发布了新的文献求助10
1秒前
1秒前
zxl完成签到,获得积分10
1秒前
qqasd完成签到,获得积分10
1秒前
YY完成签到,获得积分20
1秒前
Wtj完成签到,获得积分10
2秒前
搜集达人的应助被施妍琦采纳,获得10
2秒前
2秒前
苗青发布了新的文献求助10
2秒前
甜的桃子发布了新的文献求助10
3秒前
3秒前
lemonade发布了新的文献求助10
3秒前
wwwrh发布了新的文献求助10
3秒前
酷波er的应助被结实乐曲采纳,获得10
4秒前
泡泡糖发布了新的文献求助20
4秒前
4秒前
4秒前
完美世界的应助被Code_king采纳,获得10
5秒前
5秒前
xxxxxxzz发布了新的文献求助10
5秒前
快乐银耳汤完成签到,获得积分10
5秒前
阳光依波发布了新的文献求助10
5秒前
丘比特的应助被清秀的吐司采纳,获得10
5秒前
Hua发布了新的文献求助10
5秒前
典雅的如之完成签到,获得积分20
5秒前
6秒前
mike2012发布了新的文献求助10
6秒前
藤原拓海完成签到,获得积分20
6秒前
salaaa发布了新的文献求助10
6秒前
7秒前
7秒前
7秒前
7秒前
傲娇可仁完成签到,获得积分10
7秒前
7秒前
7秒前
Wangsw发布了新的文献求助20
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175943
求助须知:如何正确求助?哪些是违规求助? 9567501
关于积分的说明 21793186
捐赠科研通 7770490
什么是DOI,文献DOI怎么找? 3431935
关于科研通互助平台的介绍 2556294
邀请新用户注册赠送积分活动 2477485